
Our 2026 Workforce Survey Is Open
Key Takeaways
- Biopharma functions spanning CMC through supply chain are being surveyed to quantify workforce sentiment during an unstable operating environment.
- Core domains include compensation, job satisfaction, retention risk, and perceived security amid layoffs, mergers, and manufacturing-site rationalization.
How confident is the bio/pharma workforce heading into 2027? PharmTech wants to find out, and we need your input.
The 2026 Workforce Survey is now open to professionals across CMC, manufacturing, quality, regulatory, R&D, and supply chain. Its 33 questions cover the issues shaping your career right now: compensation and job satisfaction, job security amid layoffs, mergers, and site closures, and whether you’re thinking about making a move. We also want to know how AI is changing your daily work, whether your employer is providing the tools and training you need, and how tariffs, most-favored-nation pricing, and onshoring are affecting your company. Plus, we’re asking for your read on FDA predictability and your outlook for the industry and hiring in 2027.
Your answers will help paint a clear picture of how peers at startups, large pharma companies, and CDMOs are experiencing a turbulent year, and what they expect next.
Take the survey today and add your voice!
Related to this article









